Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Unraveling the In Vitro Toxicity Profile of Psychedelic 2C Phenethylamines and Their <i>N</i>-Benzylphenethylamine (NBOMe) AnaloguesDaniel Martins, Eva Gil-Martins, Fernando Cagide, et al.Veterinary Sciences|February 26, 2026
Hydroxycinnamic and Hydroxybenzoic-Based Mitochondriotropic Antioxidants Improve Bovine Embryo Quality and Cryo-SurvivalFilipa Ferreira, Beatriz Lourenço, José Teixeira, et al.European Journal of Medicinal Chemistry|September 18, 2022
Boosting caffeic acid performance as antioxidant and monoamine oxidase B/catechol-O-methyltransferase inhibitorDaniel Chavarria, Sofia Benfeito, Pedro Soares, et al.Pharmaceutics|July 25, 2019
Boosting Drug Discovery for Parkinson's: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based NanoparticlesMiguel Pinto, Carlos Fernandes, Eva Martins, et al.Redox Biology|June 20, 2021
A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patientsCláudia M Deus, Susana P Pereira, Teresa Cunha-Oliveira, et al.Journal of Medicinal Chemistry|January 30, 2023
Modulating Cytotoxicity with Lego-like Chemistry: Upgrading Mitochondriotropic Antioxidants with Prototypical Cationic Carrier BricksSofia Benfeito, Carlos Fernandes, Daniel Chavarria, et al.Free Radical Biology & Medicine|December 26, 2021
Mitochondriotropic antioxidant based on caffeic acid AntiOxCIN<sub>4</sub> activates Nrf2-dependent antioxidant defenses and quality control mechanisms to antagonize oxidative stress-induced cell damageRicardo Amorim, Fernando Cagide, Ludgero C Tavares, et al.European Journal of Medicinal Chemistry|June 30, 2022
Design and synthesis of chromone-based monoamine oxidase B inhibitors with improved drug-like propertiesJoana Reis, Carlos Fernandes, Hoda Salem, et al.Antioxidants (Basel, Switzerland)|March 6, 2021
Fine-Tuning the Biological Profile of Multitarget Mitochondriotropic Antioxidants for Neurodegenerative DiseasesDaniel Chavarria, Ophelie Da Silva, Sofia Benfeito, et al.Journal of Medicinal Chemistry|July 27, 2017
Development of a Mitochondriotropic Antioxidant Based on Caffeic Acid: Proof of Concept on Cellular and Mitochondrial Oxidative Stress ModelsJosé Teixeira, Fernando Cagide, Sofia Benfeito, et al.Pageof 4